Literature DB >> 8075266

Severe giardiasis in the United States.

E J Lengerich1, D G Addiss, D D Juranek.   

Abstract

Giardia lamblia is a common gastrointestinal pathogen but is not generally appreciated as a cause of severe illness. To describe the epidemiology of severe giardiasis, we reviewed data on hospital discharges from the United States and the state of Michigan and compared results for giardiasis with those for shigellosis. From 1979 to 1988, an estimated 4,600 persons were hospitalized for giardiasis annually in the United States; the incidence of giardiasis was 2.0 hospitalizations per 100,000 persons, compared with 2.4 hospitalizations per 100,000 persons for shigellosis. Rates of giardiasis were highest among children younger than 5 years old and women of childbearing age; the median length of hospital stay was 4 days (annual total, 23,238 days). Among residents of Michigan from 1983 to 1987, the average annual incidence of hospitalization was 1.4 per 100,000 persons for giardiasis, compared with 1.0 per 100,000 persons for shigellosis. Volume depletion was the most frequently listed codiagnosis (33.2%); 18.7% of children younger than 5 years old who had severe giardiasis had failure to thrive. Physicians should consider the diagnosis of giardiasis for persons with severe gastrointestinal illness.

Entities:  

Mesh:

Year:  1994        PMID: 8075266     DOI: 10.1093/clinids/18.5.760

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Evaluation of an immunochromatographic assay: Giardia-Strip® (Coris BioConcept) for detection of Giardia intestinalis in human fecal specimens.

Authors:  T K T Nguyen; H Kherouf; V Blanc-Pattin; E Allais; Y Chevalier; A Richez; C Ramade; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-06       Impact factor: 3.267

Review 2.  Mechanisms of Giardia lamblia differentiation into cysts.

Authors:  H D Luján; M R Mowatt; T E Nash
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

3.  IL-17A promotes protective IgA responses and expression of other potential effectors against the lumen-dwelling enteric parasite Giardia.

Authors:  Sara M Dann; Carolin F Manthey; Christine Le; Yukiko Miyamoto; Lauren Gima; Andrew Abrahim; Anthony T Cao; Elaine M Hanson; Jay K Kolls; Eyal Raz; Yingzi Cong; Lars Eckmann
Journal:  Exp Parasitol       Date:  2015-06-09       Impact factor: 2.011

4.  Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana.

Authors:  A A Escobedo; P Almirall; M Alfonso; Y Salazar; I Avila; S Cimerman; F A Núñez; I V Dawkins
Journal:  Ann Trop Med Parasitol       Date:  2011-01

Review 5.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Severe giardiasis and cryptosporidiosis in Scotland, UK.

Authors:  L J Robertson
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

Review 7.  Obstetrician-gynecologists and perinatal infections: a review of studies of the Collaborative Ambulatory Research Network (2005-2009).

Authors:  Meaghan A Leddy; Bernard Gonik; Jay Schulkin
Journal:  Infect Dis Obstet Gynecol       Date:  2010-11-11

8.  Diagnostic yield of duodenal aspirate for G. lamblia and comparison to duodenal mucosal biopsies.

Authors:  Sandeep K Gupta; Joseph M Croffie; Marian D Pfefferkorn; Joseph F Fitzgerald
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

9.  Effects of a putrescine analog on Giardia lamblia.

Authors:  C Maia; A Lanfredi-Rangel; K G Santana-Anjos; M F Oliveira; W De Souza; M A Vannier-Santos
Journal:  Parasitol Res       Date:  2008-04-24       Impact factor: 2.289

10.  Systemic and mucosal responses to oral administration of excretory and secretory antigens from Giardia intestinalis.

Authors:  Juan Carlos Jiménez; Josette Fontaine; Jean-Marie Grzych; Eduardo Dei-Cas; Monique Capron
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.